Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Bile Duct Cancer”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Looking for participantsNCT06546969
What this trial is testing

Chemoimmunotherapy Combined With Hyperthermia and Spatially-Fractionated Radiotherapy in Advanced Biliary Tract Cancer

Who this might be right for
Biliary Tract CancerCholangiocarcinoma
University of Maryland, Baltimore 15
Not applicableNot Yet RecruitingNCT07164703
What this trial is testing

A Real-World Study of Precision Treatment for Advanced Cholangiocarcinoma Based on Molecular Subtyping

Who this might be right for
Advanced Cholangiocarcinoma (Part 1)
Mao-Lin Yan 55
Testing effectiveness (Phase 2)Ended earlyNCT02994251
What this trial is testing

A Trial of Systemic Chemotherapy in Combination With Conventional Transarterial Chemoembolization in Patients With Advanced Intra-Hepatic Cholangiocarcinoma

Who this might be right for
Unresectable Intrahepatic Cholangiocarcinoma
Yale University 1
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07685535
What this trial is testing

HAIC + DEB-TACE + Toripalimab + Lenvatinib for Unresectable Intrahepatic Cholangiocarcinoma

Who this might be right for
Liver Cancer
Shanghai Zhongshan Hospital 29
Not applicableWithdrawnNCT05041335
What this trial is testing

Wet Heparinized Suction for Abdominal Cancer

Who this might be right for
Cancer of PancreasCancer of StomachCancer of Esophagus+2 more
H. Lee Moffitt Cancer Center and Research Institute
Early research (Phase 1)Study completedNCT00005860
What this trial is testing

Oxaliplatin With Or Without Floxuridine and Leucovorin in Treating Patients With Metastatic Cancer of the Peritoneum

Who this might be right for
Cancer
Memorial Sloan Kettering Cancer Center
Not applicableStudy completedNCT02104076
What this trial is testing

Evolution® Biliary Stent System-Fully Covered

Who this might be right for
Carcinomas/Neoplasms
Cook Group Incorporated 90
Testing effectiveness (Phase 2)Enrolling By InvitationNCT01868490
What this trial is testing

The Adoptive Immunotherapy for Solid Tumors Using Modified Autologous CIK Cells

Who this might be right for
CholangiocarcinomaNeuroblastoma
Siriraj Hospital 20
Not applicableStudy completedNCT06162520
What this trial is testing

Congenital Biliary Dilatation Diagnosis Based on 3D Morphological Characteristics

Who this might be right for
Congenital Biliary Dilatation
Tsinghua University 550
Testing effectiveness (Phase 2)Active Not RecruitingNCT06178588
What this trial is testing

Sacituzumab Govitecan for the Treatment for Patients With Locally Advanced, Recurrent, or Metastatic Cholangiocarcinoma

Who this might be right for
Locally Advanced CholangiocarcinomaMetastatic CholangiocarcinomaRecurrent Cholangiocarcinoma+4 more
University of Kansas Medical Center 15
Not applicableUnknownNCT02958059
What this trial is testing

Effectiveness of Prophylactic Antibiotics to Prevent Post Endoscopic Retrograde Cholangio Pancreatography Bacteremia in Biliary Obstruction Patient

Who this might be right for
Biliary Obstructive Disease Such as CholedocholithiasisBenign Biliary StricturePeri-ampullary Cancer+2 more
Yonsei University 400
Early research (Phase 1)Looking for participantsNCT05568680
What this trial is testing

SynKIR-110 for Mesothelin Expressing Ovarian Cancer, Cholangiocarcinoma or Mesothelioma

Who this might be right for
Ovarian CancerCholangiocarcinoma RecurrentMesothelioma, Malignant
Verismo Therapeutics 42
Testing effectiveness (Phase 2)UnknownNCT04298021
What this trial is testing

DDR-Umbrella Study of DDR Targeting Agents in Advanced Biliary Tract Cancer

Who this might be right for
Bile Duct CancerChemotherapy Effect
Seoul National University Hospital 74
Not applicableNot Yet RecruitingNCT05620485
What this trial is testing

Timing of Operation in Children With a Prenatal Diagnosis of Choledochal Cyst

Who this might be right for
Choledochal Cyst
Guangzhou Women and Children's Medical Center 30
Not applicableTemporarily pausedNCT04929015
What this trial is testing

Peritoneal Carcinomatosis Leveraging ctDNA Guided Treatment in GI Cancer Study (PERICLES Study)

Who this might be right for
Appendix Carcinoma by AJCC V8 StageColorectal Carcinoma by AJCC V8 StageDigestive System Neoplasm+4 more
Rutgers, The State University of New Jersey 30
Large-scale testing (Phase 3)UnknownNCT03086993
What this trial is testing

Percutaneous Hepatic Perfusion vs. Cisplatin/Gemcitabine in Patients With Intrahepatic Cholangiocarcinoma

Who this might be right for
Bile Duct CancerIntrahepatic Cholangiocarcinoma
Delcath Systems Inc. 295
Not applicableNot Yet RecruitingNCT07326189
What this trial is testing

Preoperative Right Hepatic Artery Embolization for Locally Advanced Bismuth IIIb and IV Perihilar Cholangiocarcinoma

Who this might be right for
Cholangiocarcinoma Non-resectable
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University 33
Not applicableUnknownNCT03792048
What this trial is testing

Magnetic Compressive Anastomosis for Biliojejunostomy and Pancreaticojejunostomy During Whipple's Procedure

Who this might be right for
CholangiocarcinomaPancreatic NeoplasmsDuodenal Neoplasms+2 more
First Affiliated Hospital Xi'an Jiaotong University 50
Not applicableUnknownNCT04415190
What this trial is testing

The Impact of Early Palliative Care on the Survival of Locally Advanced and / or Metastatic Cholangiocarcinoma Patients

Who this might be right for
Cholangiocarcinoma
Central Hospital, Nancy, France 150
Testing effectiveness (Phase 2)Study completedNCT01862315
What this trial is testing

Hepatic Arterial Infusion (HAI) With Floxuridine (FUDR) and Dexamethasone (Dex) Combined With Systemic Gemcitabine and Oxaliplatin in Patients With Unresectable Intrahepatic Cholangiocarcinoma (ICC)

Who this might be right for
Intrahepatic CholangiocarcinomaPeripheral CholangiocarcinomaCholangiolar Carcinoma+1 more
Memorial Sloan Kettering Cancer Center 56
Next Page